Hanwha General Insurance Co., Ltd. (000370.KS)
Seoul, KR
Operating within the South Korean market, Hanwha General Insurance Co., Ltd. delivers a comprehensive range of insurance solutions. Its long-term coverage encompasses policies for injury, diseases, property loss, and liability, alongside annuity products. Additionally, the company provides automobile insurance, including both casualty and property protection, as well as fire insurance and retirement pension plans. Established in 1946, this firm maintains its headquarters in Seoul, South Korea, and operates as a subsidiary of Hanwha Life Insurance Co., Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +6.89% | +5.12% | +3.71% | -6.06% | +28.55% | +26.91% | +58.64% | +59.36% | +51.25% | -14.01% | -59.83% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 3 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Property & Casualty: +14.1%+35.9% ★ Q1'26: +25.0% (vs Q1'25)
-
EPS growth Insurance - Property & Casualty: +27.5%+18.1% Q1'26: -23.6% (vs Q1'25)
-
FCF margin FCF growth · Insurance - Property & Casualty: +25.6%+10.9% Q1'26: +8.2% (vs Q1'25)
-
EBIT margin Insurance - Property & Casualty: +16.3%+6.4% Q1'26: +8.0% (vs Q1'25)
-
ROIC Insurance - Property & Casualty: +7.9%+9.2% ★ Q1'26: +12.5% (vs Q1'25)
-
Share dilution Insurance - Property & Casualty: +0.4%-24.3% ★ Q1'26: +0.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Property & Casualty: -0.10×2.44× Q1'26: 1.99× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 4 EPS Ana. |
Dec 2027 1 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
5.69T
est: 4.55T (+25.3%)
|
4.63T
est: 4.91T (-5.7%)
|
6.72T
est: 5.29T (+27.0%)
|
7.31T
est: 5.58T (+31.0%)
|
5.14T
est: 5.90T (-12.9%)
|
5.46T
est: 5.99T (-8.9%)
|
5.49T
est: 5.42T (+1.3%)
|
4.56T
est: 6.08T (-25.1%)
|
5.03T
est: 6.04T (-16.8%)
|
5.48T
est: 6.03T (-9.1%)
|
7.45T
est: 6.03T (+23.5%)
|
8.16T
8.16T – 8.16T
+35.3% YoY
|
8.95T
8.95T – 8.95T
+9.6% YoY
|
9.80T
9.80T – 9.80T
+9.6% YoY
|
| EBITDA |
154.76B
est: 310.22B (-50.1%)
|
171.42B
est: 335.46B (-48.9%)
|
233.31B
est: 361.07B (-35.4%)
|
152.48B
est: 380.71B (-59.9%)
|
-13.75B
est: 402.53B (-103.4%)
|
157.35B
est: 409.02B (-61.5%)
|
230.35B
est: 369.73B (-37.7%)
|
383.55B
est: 415.25B (-7.6%)
|
425.12B
est: 412.11B (+3.2%)
|
557.55B
est: 469.41B (+18.8%)
|
572.04B
est: 469.64B (+21.8%)
|
635.47B
635.47B – 635.47B
+35.3% YoY
|
696.34B
696.34B – 696.34B
+9.6% YoY
|
763.03B
763.03B – 763.03B
+9.6% YoY
|
| EBIT |
128.92B
est: 242.90B (-46.9%)
|
146.80B
est: 262.65B (-44.1%)
|
206.06B
est: 282.71B (-27.1%)
|
126.92B
est: 298.08B (-57.4%)
|
-69.66B
est: 315.17B (-122.1%)
|
93.65B
est: 320.25B (-70.8%)
|
162.27B
est: 289.48B (-43.9%)
|
310.55B
est: 325.13B (-4.5%)
|
342.35B
est: 322.67B (+6.1%)
|
461.61B
est: 378.48B (+22.0%)
|
475.18B
est: 378.67B (+25.5%)
|
512.37B
512.37B – 512.37B
+35.3% YoY
|
561.45B
561.45B – 561.45B
+9.6% YoY
|
615.22B
615.22B – 615.22B
+9.6% YoY
|
| Net Income |
95.77B
est: 160.57B (-40.4%)
|
111.63B
est: 191.49B (-41.7%)
|
147.64B
est: 206.89B (-28.6%)
|
81.76B
est: 147.05B (-44.4%)
|
-66.20B
est: -1.89B (-3,403.1%)
|
61.26B
est: 87.46B (-30.0%)
|
121.98B
est: 220.74B (-44.7%)
|
222.19B
est: 341.53B (-34.9%)
|
247.24B
est: 310.71B (-20.4%)
|
343.01B
est: 304.28B (+12.7%)
|
299.02B
est: 318.89B (-6.2%)
|
316.86B
267.01B – 374.98B
-0.6% YoY
|
357.25B
317.82B – 396.68B
+12.7% YoY
|
390.03B
390.03B – 390.03B
+9.2% YoY
|
| SGA |
269.95B
est: 652.00B (-58.6%)
|
301.45B
est: 705.04B (-57.2%)
|
346.54B
est: 758.87B (-54.3%)
|
384.10B
est: 800.13B (-52.0%)
|
406.98B
est: 846.01B (-51.9%)
|
377.49B
est: 859.65B (-56.1%)
|
408.80B
est: 777.06B (-47.4%)
|
758.13B
est: 872.74B (-13.1%)
|
927.62B
est: 866.14B (+7.1%)
|
1.22T
est: 781.60B (+56.2%)
|
—
est: 781.99B (-100.0%)
|
1.06T
1.06T – 1.06T
+35.3% YoY
|
1.16T
1.16T – 1.16T
+9.6% YoY
|
1.27T
1.27T – 1.27T
+9.6% YoY
|
| EPS |
1,035.35
est: 1,040.93 (-0.5%)
|
1,178.63
est: 1,241.37 (-5.1%)
|
1,519.00
est: 1,341.17 (+13.3%)
|
648.00
est: 953.25 (-32.0%)
|
-591.70
est: -12.25 (-4,730.2%)
|
413.32
est: 567.00 (-27.1%)
|
813.47
est: 1,431.00 (-43.2%)
|
1,616.85
est: 2,214.00 (-27.0%)
|
1,597.78
est: 2,014.25 (-20.7%)
|
2,120.83
est: 2,606.50 (-18.6%)
|
2,504.16
est: 2,731.67 (-8.3%)
|
2,714.25
2,287.26 – 3,212.15
-0.6% YoY
|
3,060.25
2,722.45 – 3,398.05
+12.7% YoY
|
3,341.00
3,341.00 – 3,341.00
+9.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | A- | 4/5 | 1/5 | 4/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-08 | A- | 4/5 | 1/5 | 4/5 | 4/5 | 2/5 | 5/5 | 5/5 |
| 2026-05-07 | A- | 4/5 | 1/5 | 4/5 | 4/5 | 2/5 | 5/5 | 5/5 |
| 2026-05-06 | A- | 4/5 | 1/5 | 4/5 | 4/5 | 2/5 | 5/5 | 5/5 |
| 2026-05-04 | A- | 4/5 | 1/5 | 4/5 | 4/5 | 2/5 | 5/5 | 5/5 |
| 2026-04-30 | A- | 4/5 | 1/5 | 4/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-29 | A- | 4/5 | 1/5 | 4/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-28 | A- | 4/5 | 1/5 | 4/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-27 | A- | 4/5 | 1/5 | 4/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-24 | A- | 4/5 | 1/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 1/5 | 4/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-22 | A- | 4/5 | 1/5 | 4/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-21 | A- | 4/5 | 1/5 | 4/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-20 | A- | 4/5 | 1/5 | 4/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-17 | A- | 4/5 | 1/5 | 4/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-16 | A- | 4/5 | 1/5 | 4/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-15 | A- | 4/5 | 1/5 | 4/5 | 5/5 | 2/5 | 4/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kang-Man Lee | Senior Managing Director of Corporate Sales | 2B | male |
| Chea Bum Na | Chief Executive Officer & Chairman | 995M | male |
| Sanghoon Yeo | Assistant Executive Director & Head of Yeongnam Regional Headquarters | 960M | male |
| Sung-Gyu Park | Executive Director of Human Resources | 711M | male |
| Jae-Woo Lee | Head of Corporate Insurance Division & Assistant Executive Director | 654M | male |
| Ji-Hun Seo | Head of Corporate Insurance Division & In-House Director | 617M | male |
| Te-Cheol Kim | MD & Director of Long-Term Insurance Department | — | male |
| Eun-Seo Jang | Assistant Executive Director & Compliance Officer | — | male |
| Jinan Ha | Head of Strategic Sales Division & Director | — | male |
| Jong-Chul Lee | MD & Director of Corporate Insurance Department | — | male |
| Nam-Ok Kim | MD & Personal Sales Officer | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 000370.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
